99m Tc-Arcitumomab, PMID: 20641871
Safety and efficacy of arcitumomab imaging in colorectal cancer after repeated administration, PMID: 10855627
Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer, PMID: 9389396
Radioiodinated T84.66 minibody, PMID: 20641489
Breast cancer imaging with radiolabeled antibodies, PMID: 9990682
Diagnosis of inferior vena cava obstruction on Tc-99m Arcitumomab (CEA scan) scintigraphy, PMID: 9676957
Studies of breast cancer imaging with radiolabeled antibodies to carcinoembryonic antigen. Immunomedics Breast Cancer Study Group, PMID: 9227788
4-[ 18 F]Fluorobenzoyl-T84.66 diabody, PMID: 20641827
111 In-1,4,7,10-Tetraazacyclododecane- N, N', N'', N'''-tetraacetic acid-T84.66 diabody, PMID: 20641644
A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels, PMID: 11776491
In vivo near-infrared fluorescence imaging of carcinoembryonic antigen-expressing tumor cells in mice, PMID: 18413884
111 In-1,4,7,10-Tetraazacyclododecane- N, N', N'', N'''-tetraacetic acid-T84.66 minibody, PMID: 20641400
Can postoperative surveillance with serial CEA immunoscintigraphy detect resectable rectal cancer recurrence and potentially improve tumor-free survival?, PMID: 11085731
Detection of distant medullary thyroid carcinoma metastases by Tc-99m arcitumomab scintigraphy, PMID: 10656657
[Comparative study of CEA antibody scan and computed tomography scan in the follow-up of patients with colorectal cancer], PMID: 12236910
Probe-guided surgery for colorectal cancer, PMID: 10857180
Clinical and technical considerations for imaging colorectal cancers with technetium-99m-labeled antiCEA Fab' fragment, PMID: 10763776
[Personal experience using radioimmunoguided surgery (RIGS)], PMID: 18338553
[Radioimmunoguided surgery (R.I.G.S.) in colorectal cancer. Preliminary results], PMID: 12192927
Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma?, PMID: 12865871
Bilateral ovarian metastases from colon carcinoma visualized on F-18 FDG PET scan, PMID: 15069335
Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG, PMID: 9189130
Immunoscintigraphy and intra-operative radioimmunodetection in the treatment of colorectal carcinoma, PMID: 12790934
Comparative tumor localization of whole immunoglobulin G anticarcinoembryonic antigen monoclonal antibodies IMMU-4 and IMMU-4 F(ab')2 in colorectal cancer patients, PMID: 8306270
FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma, PMID: 11037995
Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials, PMID: 8389662
Carcinoembryonic antigen (CEA) scan in the diagnosis of recurrent colorectal carcinoma in a patient with increasing CEA levels and inconclusive computed tomographic findings, PMID: 12819425
Radioimmunodetection of non-small cell lung cancer using technetium-99m-anticarcinoembryonic antigen IMMU-4 Fab' fragment. Preliminary results, PMID: 8306275
Contribution of an Anti-CEA Fab' scan in the detection of medullary thyroid cancer, PMID: 12045444
Incidental detection of carcinoid with Tc-99m-labeled carcinoembryonic antigen monoclonal antibody scintigraphy during evaluation of metastatic colon cancer, PMID: 10595482
Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels, PMID: 8120546
99Tcm-IMMU4 imaging in recurrent colorectal cancer: efficacy and impact on surgical management, PMID: 8843115
Detection of pelvic recurrence of colorectal carcinoma: prospective, blinded comparison of Tc-99m-IMMU-4 monoclonal antibody scanning and CT, PMID: 7480740
In vivo near-infrared fluorescence imaging of carcinoembryonic antigen-expressing tumor cells in mice., PMID:18413884
[Personal experience using radioimmunoguided surgery (RIGS)]., PMID:18338553
Bilateral ovarian metastases from colon carcinoma visualized on F-18 FDG PET scan., PMID:15069335
Is there a role for (99m)Tc-anti-CEA monoclonal antibody imaging in the diagnosis of recurrent colorectal carcinoma?, PMID:12865871
Carcinoembryonic antigen (CEA) scan in the diagnosis of recurrent colorectal carcinoma in a patient with increasing CEA levels and inconclusive computed tomographic findings., PMID:12819425
Immunoscintigraphy and intra-operative radioimmunodetection in the treatment of colorectal carcinoma., PMID:12790934
[Comparative study of CEA antibody scan and computed tomography scan in the follow-up of patients with colorectal cancer]., PMID:12236910
[Radioimmunoguided surgery (R.I.G.S.) in colorectal cancer. Preliminary results]., PMID:12192927
Contribution of an Anti-CEA Fab' scan in the detection of medullary thyroid cancer., PMID:12045444
A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels., PMID:11776491
Can postoperative surveillance with serial CEA immunoscintigraphy detect resectable rectal cancer recurrence and potentially improve tumor-free survival?, PMID:11085731
FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma., PMID:11037995
Probe-guided surgery for colorectal cancer., PMID:10857180
Safety and efficacy of arcitumomab imaging in colorectal cancer after repeated administration., PMID:10855627
Clinical and technical considerations for imaging colorectal cancers with technetium-99m-labeled antiCEA Fab' fragment., PMID:10763776
Detection of distant medullary thyroid carcinoma metastases by Tc-99m arcitumomab scintigraphy., PMID:10656657
Incidental detection of carcinoid with Tc-99m-labeled carcinoembryonic antigen monoclonal antibody scintigraphy during evaluation of metastatic colon cancer., PMID:10595482
Breast cancer imaging with radiolabeled antibodies., PMID:9990682
Diagnosis of inferior vena cava obstruction on Tc-99m Arcitumomab (CEA scan) scintigraphy., PMID:9676957
Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer., PMID:9389396
Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG., PMID:9189130
Studies of breast cancer imaging with radiolabeled antibodies to carcinoembryonic antigen. Immunomedics Breast Cancer Study Group., PMID:9227788
99Tcm-IMMU4 imaging in recurrent colorectal cancer: efficacy and impact on surgical management., PMID:8843115
Detection of pelvic recurrence of colorectal carcinoma: prospective, blinded comparison of Tc-99m-IMMU-4 monoclonal antibody scanning and CT., PMID:7480740
Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels., PMID:8120546
Radioimmunodetection of non-small cell lung cancer using technetium-99m-anticarcinoembryonic antigen IMMU-4 Fab' fragment. Preliminary results., PMID:8306275
Comparative tumor localization of whole immunoglobulin G anticarcinoembryonic antigen monoclonal antibodies IMMU-4 and IMMU-4 F(ab')2 in colorectal cancer patients., PMID:8306270
Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials., PMID:8389662
For research use only. Not for human or drug use.
